{
 "url": "https://etfiq.com/funds/pbe/holdings/",
 "section": "funds",
 "title": "PBE Holdings: All 32 Positions (Oct 13, 2026) | ETFIQ",
 "description": "All 32 PBE holdings with weights, as of Oct 13, 2026. The top 3 are ILMN 6.26%, NTRA 6.10% and BIIB 5.39%. Download the full list as a CSV.",
 "as_of": "Oct 13, 2026",
 "ticker": "PBE",
 "fund": "Invesco Biotechnology & Genome ETF",
 "fund_page": "https://etfiq.com/funds/pbe",
 "positions": 32,
 "positions_listed_on_page": 32,
 "lead": "PBE held 32 positions as of Oct 13, 2026. Illumina Inc is the largest at 6.26%; the top 10 are 49.5% of the fund.",
 "source": {
  "name": "Invesco",
  "url": "https://dng-api.invesco.com/cache/v1/accounts/en_US/shareclasses/46137V787/holdings/fund?idType=cusip&productType=ETF",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-13",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Illumina Inc",
   "ticker": "ILMN",
   "weight_pct": 6.261,
   "page": "https://etfiq.com/holdings/ilmn/"
  },
  {
   "rank": 2,
   "holding": "Natera Inc",
   "ticker": "NTRA",
   "weight_pct": 6.104,
   "page": "https://etfiq.com/holdings/ntra/"
  },
  {
   "rank": 3,
   "holding": "Biogen Inc",
   "ticker": "BIIB",
   "weight_pct": 5.386,
   "page": "https://etfiq.com/holdings/biib/"
  },
  {
   "rank": 4,
   "holding": "Gilead Sciences Inc",
   "ticker": "GILD",
   "weight_pct": 5.165,
   "page": "https://etfiq.com/holdings/gild/"
  },
  {
   "rank": 5,
   "holding": "Amgen Inc",
   "ticker": "AMGN",
   "weight_pct": 4.849,
   "page": "https://etfiq.com/holdings/amgn/"
  },
  {
   "rank": 6,
   "holding": "Royalty Pharma PLC",
   "ticker": "RPRX",
   "weight_pct": 4.734,
   "page": "https://etfiq.com/holdings/rprx/"
  },
  {
   "rank": 7,
   "holding": "Regeneron Pharmaceuticals Inc",
   "ticker": "REGN",
   "weight_pct": 4.693,
   "page": "https://etfiq.com/holdings/regn/"
  },
  {
   "rank": 8,
   "holding": "Vertex Pharmaceuticals Inc",
   "ticker": "VRTX",
   "weight_pct": 4.559,
   "page": "https://etfiq.com/holdings/vrtx/"
  },
  {
   "rank": 9,
   "holding": "Moderna Inc",
   "ticker": "MRNA",
   "weight_pct": 3.858,
   "page": "https://etfiq.com/holdings/mrna/"
  },
  {
   "rank": 10,
   "holding": "Novavax Inc",
   "ticker": "NVAX",
   "weight_pct": 3.848,
   "page": null
  },
  {
   "rank": 11,
   "holding": "Exelixis Inc",
   "ticker": "EXEL",
   "weight_pct": 2.973,
   "page": "https://etfiq.com/holdings/exel/"
  },
  {
   "rank": 12,
   "holding": "United Therapeutics Corp",
   "ticker": "UTHR",
   "weight_pct": 2.97,
   "page": "https://etfiq.com/holdings/uthr/"
  },
  {
   "rank": 13,
   "holding": "Qiagen N.V.",
   "ticker": "QGEN",
   "weight_pct": 2.95,
   "page": "https://etfiq.com/holdings/qia/"
  },
  {
   "rank": 14,
   "holding": "Halozyme Therapeutics Inc",
   "ticker": "HALO",
   "weight_pct": 2.841,
   "page": "https://etfiq.com/holdings/halo/"
  },
  {
   "rank": 15,
   "holding": "TG Therapeutics Inc",
   "ticker": "TGTX",
   "weight_pct": 2.778,
   "page": "https://etfiq.com/holdings/tgtx/"
  },
  {
   "rank": 16,
   "holding": "Veracyte Inc",
   "ticker": "VCYT",
   "weight_pct": 2.774,
   "page": "https://etfiq.com/holdings/vcyt/"
  },
  {
   "rank": 17,
   "holding": "Repligen Corp",
   "ticker": "RGEN",
   "weight_pct": 2.736,
   "page": "https://etfiq.com/holdings/rgen/"
  },
  {
   "rank": 18,
   "holding": "Vericel Corp",
   "ticker": "VCEL",
   "weight_pct": 2.642,
   "page": "https://etfiq.com/holdings/vcel/"
  },
  {
   "rank": 19,
   "holding": "Protagonist Therapeutics Inc",
   "ticker": "PTGX",
   "weight_pct": 2.606,
   "page": "https://etfiq.com/holdings/ptgx/"
  },
  {
   "rank": 20,
   "holding": "Neurocrine Biosciences Inc",
   "ticker": "NBIX",
   "weight_pct": 2.497,
   "page": "https://etfiq.com/holdings/nbix/"
  },
  {
   "rank": 21,
   "holding": "Sarepta Therapeutics Inc",
   "ticker": "SRPT",
   "weight_pct": 2.473,
   "page": "https://etfiq.com/holdings/srpt/"
  },
  {
   "rank": 22,
   "holding": "Legend Biotech Corp",
   "ticker": "LEGN",
   "weight_pct": 2.379,
   "page": null
  },
  {
   "rank": 23,
   "holding": "Incyte Corp",
   "ticker": "INCY",
   "weight_pct": 2.373,
   "page": "https://etfiq.com/holdings/incy/"
  },
  {
   "rank": 24,
   "holding": "Ardelyx Inc",
   "ticker": "ARDX",
   "weight_pct": 2.339,
   "page": null
  },
  {
   "rank": 25,
   "holding": "BioMarin Pharmaceutical Inc",
   "ticker": "BMRN",
   "weight_pct": 2.33,
   "page": "https://etfiq.com/holdings/bmrn/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash & Equivalents",
   "weight_pct": 0.001
  },
  {
   "holding": "Cash and other net assets",
   "weight_pct": 0.001
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/pbe/holdings/pbe-holdings.csv",
 "json_book": "https://etfiq.com/data/books/pbe.json",
 "markdown": "https://etfiq.com/funds/pbe/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of PBE, data as of Oct 13, 2026. https://etfiq.com/funds/pbe/holdings/"
}